REGULATORYRFK Jr.: 14 peptides returning to Category 1 — FDA advisory committee July 2026TRENDINGHexarelin: ↑↑ Surging ��� Trends score 100 as of May 2026UPDATESemaglutide and tirzepatide compounding ended — shortage resolved Feb/May 2025REGULATORYBPC-157, TB-500, thymosin alpha-1, CJC-1295, ipamorelin: expected Category 1 reclassification pendingEVENTpep-talk con ��� First US Peptide Convention · August 2026 · Anaheim CAFDAFDA advisory committee meetings scheduled: late July 2026REGULATORYRFK Jr.: 14 peptides returning to Category 1 — FDA advisory committee July 2026TRENDINGHexarelin: ↑↑ Surging ��� Trends score 100 as of May 2026UPDATESemaglutide and tirzepatide compounding ended — shortage resolved Feb/May 2025REGULATORYBPC-157, TB-500, thymosin alpha-1, CJC-1295, ipamorelin: expected Category 1 reclassification pendingEVENTpep-talk con ��� First US Peptide Convention · August 2026 · Anaheim CAFDAFDA advisory committee meetings scheduled: late July 2026

For research purposes only. Full disclaimer →

Questions & Help
-5

Semaglutide week 12 check-in

Ellis Chen 29·4 days ago
This is a topic that does not get discussed enough. I think the community would benefit from a thorough discussion about the science behind this, potential risks, and realistic expectations.

Comments (4)

Sasha Murphy 640·about 2 months ago

I have been doing something similar for about 3 months now. The first few weeks were unremarkable but results became noticeable around week 4-5.

2
Sasha Johansson 740·about 1 month ago

I have been doing something similar for about 3 months now. The first few weeks were unremarkable but results became noticeable around week 4-5.

0
Sasha Nakamura 840·20 days ago

I have been doing something similar for about 3 months now. The first few weeks were unremarkable but results became noticeable around week 4-5.

0
Sasha Chen 40·4 days ago

I have been doing something similar for about 3 months now. The first few weeks were unremarkable but results became noticeable around week 4-5.

2

Sign in to comment.